Clinical Trials Browser

Withdrawn × INDUSTRY × Denosumab × Clear all

NCT02101164 2015-02-18

Evaluate Time Associated With the Preparation & Administration of Denosumab/Pamidronate in Patients With Solid Tumors and Metastatic Bone Disease

Phase 4 Withdrawn

Bone Diseases